US Stock MarketDetailed Quotes
PFE Pfizer
- 28.270
- +0.500+1.80%
Close May 8 16:00 ET
- 27.900
- +0.050+0.18%
Pre 06:39 ET
160.08BMarket Cap-565400P/E (TTM)
28.340High27.520Low39.09MVolume27.700Open27.770Pre Close1.10BTurnover0.69%Turnover Ratio76.41P/E (Static)5.66BShares38.22852wk High1.80P/B159.83BFloat Cap24.82652wk Low1.65Dividend TTM5.65BShs Float55.488Historical High5.84%Div YieldTTM2.95%Amplitude5.554Historical Low28.147Avg Price1Lot Size
Pfizer Stock Forum
Sign in to post a comment
ColumnsOptions Market Statistics: Uber Stock Skids Lower, Options Pop On Q1 Bookings Miss, Unexpected Loss
News Highlights
$Pfizer(PFE.US$ shares ended 1.80% higher, with option volume of nearly 1.29 million contracts, and calls accounted for 96.8% of the volume. The most traded calls are contracts of $27 strike price that expire on May 10th. The total volume reaches 260,356 with an open interest of 43,909.
$Uber Technologies(UBER.US$ shares ended 5.72% lower, with option volume of nearly 0.44 millio...
$Pfizer(PFE.US$ shares ended 1.80% higher, with option volume of nearly 1.29 million contracts, and calls accounted for 96.8% of the volume. The most traded calls are contracts of $27 strike price that expire on May 10th. The total volume reaches 260,356 with an open interest of 43,909.
$Uber Technologies(UBER.US$ shares ended 5.72% lower, with option volume of nearly 0.44 millio...
18
1
1
1
$Pfizer(PFE.US$ 🎉🎉🎉🚀🚀🚀
$Pfizer(PFE.US$
Young participant in Pfizer’s Phase 2 DAYLIGHT trial passes away.
Study examines gene therapy for Duchenne muscular dystrophy.
Pfizer pauses dosing in related Phase 3 CIFFREO trial.
Company working with regulators to investigate the incident.
Other trial activities continue despite dosing pause.
Pfizer committed to transparency and ongoing communication.
Community expresses deep sorrow and calls for support
$Moderna(MRNA.US$ $Johnson & Johnson(JNJ.US$ $Eli Lilly and Co(LLY.US$ $AbbVie(ABBV.US$
Young participant in Pfizer’s Phase 2 DAYLIGHT trial passes away.
Study examines gene therapy for Duchenne muscular dystrophy.
Pfizer pauses dosing in related Phase 3 CIFFREO trial.
Company working with regulators to investigate the incident.
Other trial activities continue despite dosing pause.
Pfizer committed to transparency and ongoing communication.
Community expresses deep sorrow and calls for support
$Moderna(MRNA.US$ $Johnson & Johnson(JNJ.US$ $Eli Lilly and Co(LLY.US$ $AbbVie(ABBV.US$
1
See summary 👇
📣 4 PDUFAs upcoming in May:
$Dynavax Technologies(DVAX.US$ : 🤔
⇒ Heplisav-B
‣ vaccination of adults on hemodialysis
‣ PDUFA date: 5/13/24 (sBLA)
$Ascendis Pharma A/S(ASND.US$ : 🤔
⇒ YORVIPATH®
‣ hypoparathyroidism
‣ PDUFA date: 5/14/24 (NDA)
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇒ Breyanzi®
‣ PDUFA dates: (sBLAs)
‣‣ 5/23/24 (r/r follicular lymphoma)
‣‣ 5/31/24 (r/r mantle cell lymphoma)
🗓️ Last week’s PDUFAs:
$X4 Pharmaceuticals(XFOR.US$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
‣ WHI...
📣 4 PDUFAs upcoming in May:
$Dynavax Technologies(DVAX.US$ : 🤔
⇒ Heplisav-B
‣ vaccination of adults on hemodialysis
‣ PDUFA date: 5/13/24 (sBLA)
$Ascendis Pharma A/S(ASND.US$ : 🤔
⇒ YORVIPATH®
‣ hypoparathyroidism
‣ PDUFA date: 5/14/24 (NDA)
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇒ Breyanzi®
‣ PDUFA dates: (sBLAs)
‣‣ 5/23/24 (r/r follicular lymphoma)
‣‣ 5/31/24 (r/r mantle cell lymphoma)
🗓️ Last week’s PDUFAs:
$X4 Pharmaceuticals(XFOR.US$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
‣ WHI...
6
2
$Pfizer(PFE.US$
PFE finally looked like it had broken above resistance. As long as we close the week about 27.94, we have a seed for an uptrend or a change in trend. This downtrend has been alive for over 2 years. it's time for a change.
PFE finally looked like it had broken above resistance. As long as we close the week about 27.94, we have a seed for an uptrend or a change in trend. This downtrend has been alive for over 2 years. it's time for a change.
6
Top 10 drug companies raked in NEARLY TRIPLE the revenue in 2023 ($491B) vs 2013 ($165B) 2013 vs. 2023.
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
3
1
Happy Friday, mooers! Welcome back to Weekly Buzz, where we review the news, performance, and community sentiment of buzzing stocks on moomoo based on search and message volumes of this week! Make sure to comment below to answer the Weekly Topic question for a chance to win an award next week!
-Kevin Travers, moomoo news
Make Your Choice
Weekly Buzz
Friday, the market was green. The FOMC no-change decision Wednesd...
-Kevin Travers, moomoo news
Make Your Choice
Weekly Buzz
Friday, the market was green. The FOMC no-change decision Wednesd...
+10
26
9
15
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
103707939 : 如股票就是这个样子的啦